Kane Biotech Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
| Date | Value | Name | Entity | Role | Shares | Max Price |
|---|---|---|---|---|---|---|
| 01 Oct 24 | BuyUS$22,408 | Robert Huizinga | Individual | 242,000 | US$0.093 | |
| 13 Sep 24 | BuyUS$8,283 | Robert Huizinga | Individual | 90,000 | US$0.092 | |
| 11 Sep 24 | BuyUS$183,815 | Richard Renaud | Individual | 2,500,000 | US$0.074 | |
| 29 Jul 24 | BuyUS$14,616 | Marc Edwards | Individual | 150,000 | US$0.097 | |
| 25 Jun 24 | BuyUS$35,369 | Marc Edwards | Individual | 345,000 | US$0.10 | |
| 17 Apr 24 | SellUS$188,348 | Philip Renaud | Individual | 2,000,000 | US$0.094 |
Insider Trading Volume
Insider Buying: KNBI.F insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Individual Insiders | 50,370,590 | 36.6% |
| General Public | 87,140,977 | 63.4% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 4.3%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 25,389,711 | US$2.0m | 0% | no data | |||
| 17,130,333 | US$1.3m | 17.1% | no data | |||
| 6,383,142 | US$502.3k | 2.41% | no data | |||
| 985,404 | US$77.5k | 0% | no data | |||
| 332,000 | US$26.1k | 269% | no data | |||
| 150,000 | US$11.8k | 0% | no data |